Merrimack Pharmaceuticals, Inc. (MACK)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 01:50PM EDT. Market open.
| Previous close | 12.03 |
| Open | 12.00 |
| Bid | 12.14 x 800 |
| Ask | 12.17 x 800 |
| Day's range | 12.00 - 12.23 |
| 52-week range | 3.00 - 13.66 |
| Volume | |
| Avg. volume | 137,801 |
| Market cap | 173.271M |
| Beta (5Y monthly) | 1.86 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.11 |
| Earnings date | 03 May 2023 - 08 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 13 Dec 2019 |
| 1y target est | 4.00 |
- Business Wire
Merrimack Reports Full Year 2022 Financial Results
CAMBRIDGE, Mass., March 09, 2023--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) ("Merrimack" or the "Company") today announced its full year 2022 financial results for the period ended December 31, 2022.
- Simply Wall St.
Merrimack Pharmaceuticals (NASDAQ:MACK) Is In A Strong Position To Grow Its Business
We can readily understand why investors are attracted to unprofitable companies. For example, Merrimack Pharmaceuticals...
- Simply Wall St.
Bullish Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) insiders filled their treasuries with US$574k worth of stock over last year
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
© 2023 Yahoo. All rights reserved.
